ArticleCureus2026
A Family With Discordant Germline BRCA1 and BRCA2 Variants: A BRCA1-Positive Mother and BRCA2-Positive Daughter With Possible Paternal Inheritance.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary breast and ovarian cancer (HBOC) is primarily caused by germline pathogenic variants in BRCA1 or BRCA2. Although a single pathogenic variant usually explains cancer predisposition within a family, independent pathogenic variants may coexist and complicate risk assessment and genetic counseling. We report a 43-year-old woman with right breast cancer in whom germline genetic testing identified a pathogenic BRCA2 variant, c.2808_2811del (p.Ala938ProfsTer21). Her mother developed primary peritoneal carcinoma at the age of 77. Tumor genomic testing identified a BRCA1 deletion of exons 1-12, which was subsequently confirmed as a germline variant. No pathogenic BRCA2 variant was detected in the mother. These discordant findings suggest that the daughter's BRCA2 variant may have been inherited through the paternal lineage or may have arisen de novo. The father was deceased and unavailable for genetic testing, and the paternal family history was uninformative. This case demonstrates that multiple independent BRCA pathogenic variants may coexist within a single family. Restricting cascade testing to a single known familial variant may therefore result in incomplete hereditary cancer risk assessment. Comprehensive germline evaluation and individualized, pedigree-based genetic counseling should be considered when clinical findings are discordant with a known familial variant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.